- Home
- IMNM vs SENS Comparison
IMNM vs SENS Comparison
Compare IMNM & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- SENS
- Stock Information
- Founded
- IMNM 2006
- SENS 1996
- Country
- IMNM United States
- SENS United States
- Employees
- IMNM N/A
- SENS N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- SENS Industrial Machinery/Components
- Sector
- IMNM Health Care
- SENS Industrials
- Exchange
- IMNM Nasdaq
- SENS Nasdaq
- Market Cap
- IMNM 747.7M
- SENS 179.7M
- IPO Year
- IMNM 2020
- SENS N/A
- Fundamental
- Price
- IMNM $10.97
- SENS $0.47
- Analyst Decision
- IMNM Strong Buy
- SENS Strong Buy
- Analyst Count
- IMNM 5
- SENS 1
- Target Price
- IMNM $28.60
- SENS $2.00
- AVG Volume (30 Days)
- IMNM 874.7K
- SENS 12.6M
- Earning Date
- IMNM 11-13-2024
- SENS 11-07-2024
- Dividend Yield
- IMNM N/A
- SENS N/A
- EPS Growth
- IMNM N/A
- SENS N/A
- EPS
- IMNM N/A
- SENS N/A
- Revenue
- IMNM $10,129,000.00
- SENS $22,205,000.00
- Revenue This Year
- IMNM N/A
- SENS $1.05
- Revenue Next Year
- IMNM N/A
- SENS $61.23
- P/E Ratio
- IMNM N/A
- SENS N/A
- Revenue Growth
- IMNM N/A
- SENS 11.41
- 52 Week Low
- IMNM $8.33
- SENS $0.25
- 52 Week High
- IMNM $30.96
- SENS $0.75
- Technical
- Relative Strength Index (RSI)
- IMNM 39.61
- SENS 68.29
- Support Level
- IMNM $10.76
- SENS $0.40
- Resistance Level
- IMNM $15.13
- SENS $0.46
- Average True Range (ATR)
- IMNM 0.98
- SENS 0.05
- MACD
- IMNM -0.29
- SENS 0.01
- Stochastic Oscillator
- IMNM 4.81
- SENS 71.19
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.